There is no
consensus on how to report total joint replacement (TJR) trials. To our
knowledge, core outcome domains for TJR clinical trials have not been defined.
Our objective was
to develop data-driven, consensus-based,
preliminary recommendations for core outcome domains for TJR
clinical trials.
We surveyed two
groups of experts/stakeholders, who rated potential core outcome domains
(mapped to Outcome Measures in Rheumatology Trials filter 2.0 framework) for
their relevance to TJR clinical trials during the 2014 American Academy of
Orthopaedic Surgeons.
No comments:
Post a Comment